ScholarIQanswers from OpenAlex

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study

PaperCitations, authors & open-access status

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study have?

ScholarIQcitation count

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study has 67 citations in the OpenAlex counts ScholarIQ stores.

When was Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study published?

ScholarIQyear

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study has 2018 year in the ScholarIQ index.

What is the open-access status of Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study?

ScholarIQoa status

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study has closed oa status in the ScholarIQ index.

What is the DOI of Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study?

ScholarIQdoi

The DOI for Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study is on the source record.

What is the PMID of Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study?

ScholarIQpmid

The PMID for Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study is on the source record.

What is the OpenAlex record for Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study?

ScholarIQopenalex

The OpenAlex for Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial